Testing a new way to diagnose lung transplant rejection using molecular analysis

This research study is testing a new diagnostic tool called the Molecular Microscope Diagnostic System (MMDx) that analyzes lung biopsy samples at the molecular level to better detect rejection in lung transplant patients. The study compares this new molecular approach to the current standard method of examining biopsies under a microscope to see if it provides more accurate diagnoses. Researchers hope this new system will help doctors identify rejection problems earlier and more reliably, so transplant patients can receive the right treatment at the right time.

Currently, doctors use a standard method to diagnose lung transplant rejection that relies on visual examination of biopsies, but this method frequently misses or misidentifies rejection problems, which can lead to patients receiving inappropriate treatment. This study exists to validate a new molecular-based diagnostic approach that may be significantly more accurate and help improve outcomes for lung transplant recipients.